Publication:

Shank is a dose-dependent regulator of Cav1 calcium current and CREB target expression

Loading...
Thumbnail Image

Open/View Files

Date

2017

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

eLife Sciences Publications, Ltd
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Pym, Edward, Nikhil Sasidharan, Katherine L Thompson-Peer, David J Simon, Anthony Anselmo, Ruslan Sadreyev, Qi Hall, Stephen Nurrish, and Joshua M Kaplan. 2017. “Shank is a dose-dependent regulator of Cav1 calcium current and CREB target expression.” eLife 6 (1): e18931. doi:10.7554/eLife.18931. http://dx.doi.org/10.7554/eLife.18931.

Abstract

Shank is a post-synaptic scaffolding protein that has many binding partners. Shank mutations and copy number variations (CNVs) are linked to several psychiatric disorders, and to synaptic and behavioral defects in mice. It is not known which Shank binding partners are responsible for these defects. Here we show that the C. elegans SHN-1/Shank binds L-type calcium channels and that increased and decreased shn-1 gene dosage alter L-channel current and activity-induced expression of a CRH-1/CREB transcriptional target (gem-4 Copine), which parallels the effects of human Shank copy number variations (CNVs) on Autism spectrum disorders and schizophrenia. These results suggest that an important function of Shank proteins is to regulate L-channel current and activity induced gene expression. DOI: http://dx.doi.org/10.7554/eLife.18931.001

Description

Research Data

Keywords

, Shank, SHN-1, L-type channel, CREB, autism

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Related Stories